Meningioma by Site — Trials

Meningioma by Site — Trials · CancerIndex

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02847559	Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma	completed	Phase 2	20	Northwestern UniversityOTHER	1	Sep 9, 2026	clinicaltrials
NCT06955169	Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment(MOMENTUM-1)	recruiting	Phase 2	130	RTOG Foundation, Inc.OTHER	1	Sep 8, 2026	clinicaltrials
NCT02523014	Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas	recruiting	Phase 2	124	Alliance for Clinical Trials in OncologyOTHER	1	Sep 2, 2026	clinicaltrials

Data updated 21 days agoSource updated Sep 9, 2026source: clinicaltrials